GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
1. Antonioli L, Blandizzi C, Pacher P, Haskó G. (2013) Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer, 13 (12): 842-57. [PMID:24226193]
2. Beamer E, Gölöncsér F, Horváth G, Bekő K, Otrokocsi L, Koványi B, Sperlágh B. (2016) Purinergic mechanisms in neuroinflammation: An update from molecules to behavior. Neuropharmacology, 104: 94-104. [PMID:26384652]
3. Borea PA, Gessi S, Merighi S, Varani K. (2016) Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?. Trends Pharmacol Sci, 37 (6): 419-34. [PMID:26944097]
4. Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. (2017) Pathological overproduction: the bad side of adenosine. Br J Pharmacol, 174 (13): 1945-1960. [PMID:28252203]
5. Haskó G, Linden J, Cronstein B, Pacher P. (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov, 7 (9): 759-70. [PMID:18758473]